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https://doi.org/10.1016/j.stemcr.2017.12.021SUMMARYAstrocytes, the most populous glial cell type in the brain, are critical for regulating the brain microenvironment. In various neurodegen-
erative diseases, astrocytes determine the progression and outcomeof the neuropathological process.Wehave recently revealed the direct
involvement of mitochondrial function in human pluripotent stem cell (hiPSC)-derived dopaminergic (DA) neuronal differentiation.
Using the astroglial-neuronal co-culture system, we show here that astrocytes effectively rescue defects in neurogenesis of DA neurons
withmitochondrial respiratory chain disruption. Co-culture of astrocytes with defective DA neurons completely restoredmitochondrial
functions and dynamics insulted by mitochondrial toxins. These results suggest the significance of astroglia in maintaining mitochon-
drial development and bioenergetics during differentiation of hiPSC-derived DA neurons. Our study also provides an active astroglial-
neuronal interaction model for future investigation of mitochondrial involvement in neurogenesis and neurodegenerative diseases.INTRODUCTION
Human pluripotent stem cells (hiPSCs) offer an attractive
tool for modeling brain development and disease based on
their ability to be directed and differentiated into human ce-
rebral organoids and cells (Lancaster and Knoblich, 2014).
Generated from hiPSCs, neural progenitor cells (NPCs) can
be used to generate neuronal and glial cells (Maroof et al.,
2013; Sofroniew and Vinters, 2010). Direction of these cells
into specific cell types allows for identification of the under-
lying neuropathology and also presents the possibility of
replacement therapy for neurodegenerative diseases such
as Parkinson’s disease (PD), which is caused by selective
loss of dopaminergic (DA) neurons in the substantia nigra
pars compacta in the midbrain (Kriks et al., 2011).
We have recently revealed (Fang et al., 2016a, 2016b) an
active and pivotal role for mitochondria in midbrain DA
and cortical neurogenesis. Induced defects in mitochon-
drial respiratory chains via application of a complex IV
inhibitor, KCN (potassium cyanide), or complex I inhibitor,
rotenone, restricted neurogenesis of DA neurons. Accumu-
lating studies have demonstrated that astrocytes, the most
populous glial cells and important coordinative partners
toneighboringneuronal cells, are essential inDAneurogen-
esis in the subventricular zone of the lateral ventricles, a re-
gion for neurogenesis in the midbrain of adult brains, and
disruption in astrocytic function promotes neurodegenera-
tion (Lo, 2010). Here, we induced DA neuron differentia-
tion with mature astrocyte co-culture, to mimic the in vivo
neuronal-astroglial interaction environment. In the pres-
ence of astrocytes, NPCs were resistant to mitochondrial
respiratory defects and exhibited normal differentiation366 Stem Cell Reports j Vol. 10 j 366–374 j February 13, 2018 j ª 2018 The
This is an open access article under the CC BY-NC-ND license (http://creativinto DA neurons. Importantly, using this dynamic astro-
cyte-neuron interaction model, we clearly display the
essential role of mitochondria in DA neuronal differentia-
tion and maturation. Furthermore, astrocytes actively
modulate normal neuronal development by rescuing
neuronal mitochondrial defects in the process of DA-dir-
ected differentiation. This human neuron-glia cross-talk
model will facilitate evaluation of the role of astrocytes in
modulating mitochondrial function in the pathogenesis
of neurodegenerative diseases and identification of thera-
peutic applications in mitochondrial degeneration.RESULTS
Efficient Differentiation of GFAP+ Mature Human
Astrocytes from NPCs
We have previously shown that human DA neurons are
derived from NPCs (Fang et al., 2016a). In this study,
NPCs derived from BM2-3 hiPSCs were differentiated into
astrocytes. Following the protocol shown in Figure S1A,
S100b-positive cells were derived from astroglial progenitor
cells after about 70 days induction with ciliary neurotro-
phic factor (CNTF) in astroglial medium (Figures S1B and
S1C). Emergence of an astrocyte-like phenotype following
70 days induction was indicated by expression of the
astrocyte markers S100b and GFAP (Figure S1A).
Populations of GFAP-positive astrocytes were robustly
increased between the 3rd and the 9th month of differen-
tiation by removing growth factors epidermal growth fac-
tor (EGF) and fibroblast growth factor 2 (FGF2) (Figures
S1B and S1C). Definitive mature astrocytes with expressionAuthors.
ecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Differentiation and Develop-
ment of hiPSC Line-Induced Human Dopa-
minergic Neurons and Astrocytes
(A) A schematic representation of the dif-
ferentiation of mitochondrial inhibitor/
toxin (KCN or rotenone)-treated hiPSC line-
induced DA neurons with astroglial co-cul-
ture. EB, embryoid body.
(B) Immunocytochemistry of synaptophysin
(Syn)-positive (green) puncta and TH (red)
in neural progenitor cells (NPCs; I) and
mature DA neurons (II) and mature as-
troglial marker (GFAP, green) and astroglial
progenitor marker (S100b, red) in NPCs (III)
and astrocytes induced for 9 months (IV).
(C) Representative immunoblots for GFAP
and TH expression in NPCs, astrocytes
induced for 9 months, and DA neurons.
b-actin was used as a protein loading con-
trol. **p < 0.01 versus NPCs and DA neurons
(open bars, GFAP), and ##p < 0.01 versus
NPCs and DA neurons (black bars, TH).
Scale bars, 25 mm in (B). For (C), statistical
analysis was performed using StatView
software (SAS Institute, v.5.0.1). One-way
ANOVA was used for repeated-measure
analysis, followed by Fisher’s protected least
significant difference for post hoc compar-
isons. Data are presented as means ± SEM.
n = 3 independent experiments.of GFAP appeared 3 to 9 months following removal of
growth factors EGF and FGF2 from astroglial medium
(Figures S1B and S1C). Astrocyte maturation was character-
ized by the presence of the astrocyte marker GFAP (Figures
1B, 1C, and S1C). Quantification of GFAP-positive cells
showed that the percentage of GFAP-expressing cells was
27.7% and 83.8% with 3 and 9 months of differentiation,
respectively (quantification data not shown). In contrast,
GFAP expression in human DA neuronal cultures was
barely detected compared with astroglial culture (Figures
1C and S1D). DA neurons were verified by the absence of
TH (tyrosine hydroxylase) expression in 9-month astroglial
culture (Figures 1B, 1C, and S1D). Therefore, 9-month
mature astrocytes were used in our co-culture system.
Co-culture with Astrocytes Rescues Impaired DA
Neuronal Differentiation and Synaptogenesis
Accumulating evidence indicates the emerging role of astro-
cytes in the pathogenesis of neurological disorders, such as
PD (Maragakis and Rothstein, 2006). Given the importance
of mitochondrial respiratory function in DA neuron differ-entiation and synaptogenesis (Fang et al., 2016a),we investi-
gated the effect of astrocytes on DA neuronal development
under respiratory chain impairment using a neuron-astro-
cyte co-culture system. Impairment of mitochondrial respi-
ratory function was induced by the addition of inhibitor
for complex IV (KCN, 500 nM) and complex I (rotenone,
10 nM), as we previously described (Fang et al., 2016a).
Consistent with our previous results, KCN- or rotenone-
induced inhibition of mitochondrial respiratory function
significantly suppressed synapse development and matura-
tion of DA neurons. However, with astrocyte co-culture,
the lengths of MAP2 (a marker for neuronal dendrites)- and
TH (a marker for DA neurons)-positive processes of neurons
were significantly longer compared with those neurons
without astrocyte co-culture in the presence of KCN or rote-
none (Figures 2A and 2B). The number of synaptophysin-
positive puncta in TH dendrites was also significantly
increased (Figures 2A and 2C). Accordingly, quantitative
real-time PCR showed that levels of mature DA neuronal
markers, including aromatic L-amino acid decarboxylase
(AADC),dopamine transporter (DAT), and vesicularmonoamineStem Cell Reports j Vol. 10 j 366–374 j February 13, 2018 367
Figure 2. Astrocyte Co-culture Rescues Differentiation of hiPSC Line-Induced Human DA Neurons under KCN or Rotenone
Treatment
(A) Representative images for immunostaining of MAP2 (green), TH (red), and Syn (white, color changed from far red) in induced DA
neurons treated with KCN or rotenone with or without astrocyte co-culture. Scale bars, 25 mm.
(B) Quantification of neuronal process length of MAP2-positive neurons and TH-positive DA neurons using NIH ImageJ program.
(C) Quantification of numbers of Syn-positive clusters along the branches of hiPSC-derived DA neurons (TH-positive dendrites).
(D–G) Quantitative real-time PCR results of the indicated gene expression levels of AADC (D), DAT (E), VMAT2 (G), and MAP2 (F) in DA
neurons with (+) or without () co-culture of astrocytes in the presence of vehicle, KCN, or rotenone.
Scale bars, 25 mm in (A). For (B)–(G), **p < 0.01 versus the vehicle group. Statistical analysis was performed using StatView software (SAS
Institute, v.5.0.1). One-way ANOVA was used for repeated-measure analysis, followed by Fisher’s protected least significant difference for
post hoc comparisons. Data are presented as means ± SEM. n = 3 independent experiments, with 12–13 cells quantified per experiment in
(B) and (C). n = 3 independent experiments in (D)–(G).transporter 2 (VMAT2), and the marker for mature neurons,
microtubule-associated protein 2 (MAP2), were markedly
elevated with astroglia co-culture (Figures 2D–2G). These re-
sults indicate that co-culture with astrocytes restores DA
neuronal differentiation ability and synaptogenesis by
improving mitochondrial function. Given that soma size is
an important index for neuronal morphology and develop-
ment, we further analyzed soma size of DA neurons in the
aforementioned treatments. No significant changes in
soma sizeofDAneuronswere observedbetweenDAneurons
with and without astrocyte co-culture exposed to KCN or
rotenone (data not shown).
Co-culture with Astrocytes Rescues Mitochondrial
Defects in hiPSC-Differentiated DA Neurons
To further determine the effect of astroglial co-culture on
neuronalmitochondrial functions,we evaluated the activity
of mitochondrial complexes I and IV (key respiratory chain
enzymes), ATP levels, and mitochondrial reactive oxygen
species (ROS) levels. Co-culture with astrocytes rescued368 Stem Cell Reports j Vol. 10 j 366–374 j February 13, 2018KCN or rotenone-induced mitochondrial dysfunction as
shown by increased complex IV and I activities and ATP
levels in DA neurons (Figures 3A–3C). Furthermore, in the
presence of astrocytes, mitochondrial ROS levels evaluated
by MitoSOX staining intensity in TH+ neuronal terminals
(Figures 3D and 3E) and intracellular ROS levels measured
by highly specific electron paramagnetic resonance (EPR)
spectroscopy (Figures 3F and 3G) were both significantly
diminished in DA neurons exposed to KCN or rotenone.
These results demonstrate that astroglial co-culture rescues
mitochondrial respiratory function defects and eliminates
ROS overproduction and accumulation during differentia-
tion of hiPSCs into DA neurons.
Co-culture with Astrocytes Protects against
Mitochondria Toxin-Induced Alterations in
Mitochondrial Morphology and Mobility in hiPSC-
Differentiated DA Neurons
Finally, we investigated mitochondrial morphology and
mobility in the processes of hiPSC-differentiated DA
Figure 3. Effect of Astrocyte Co-culture on Mitochondrial Functions in hiPSC Line-Induced Human DA Neurons under KCN or
Rotenone Treatment
(A–C) Complex IV (A) and I (B) activity and ATP levels (C) were determined in hiPSC-derived DA neurons treated with KCN or rotenone with
or without astrocyte co-culture. Data are expressed as fold change relative to the vehicle group in (A)–(C) (n = 3 independent experiments;
mean ± SEM).
(legend continued on next page)
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neurons. Cumulative distribution data in Figure 4A clearly
demonstrate that astroglial co-culture increases the per-
centage of long mitochondria in hiPSC-differentiated DA
neurons under KCN or rotenone treatment. Mitochondrial
travel distance and velocity were significantly increased in
DA neurons co-cultured with astrocytes compared with DA
neurons without astrocytes in the presence of KCN or rote-
none (Figures 4B and 4C). Similarly, the percentages of
anterograde, retrograde, and movable mitochondria were
all increased (Figures 4D and 4E), whereas the percentage
of stationary mitochondria was decreased in neurons
cultured with astrocytes (Figure 4D). Representative kymo-
graph images revealed more movable mitochondria in the
neuronal processes of KCN- and rotenone-treated DA neu-
rons with astroglial co-culture (Figure 4F). Video recorded
from living mitochondrial images revealed a significant
improvement in mitochondrial movement speed and
travel distance with astrocyte co-culture (Movie S1).
Collectively, our results indicate that astrocytes reverse
mitochondrial morphological and dynamic defects in
hiPSC-derived DA neurons insulted by mitochondrial
toxins.DISCUSSION
Accumulating evidence now suggests that astrocytes are
key neuromodulators that actively communicate/cross
talk with neurons during different phases of neurodevelop-
ment (Kettenmann and Verkhratsky, 2008; Sofroniew and
Vinters, 2010). Astroglial cells are involved inmany cellular
functions, including providing trophic support for neu-
rons, neurotransmission, metabolite and electrolyte ho-
meostasis, cell signaling, inflammation, and synapse mod-
ulation in the CNS (Rouach et al., 2008). Loss of normal
homeostatic function, toxic stimulation, or a combination
of both activates astrocytes, contributing to the neuropa-
thology of neurodegenerative diseases (Allaman et al.,
2011; Booth et al., 2017).
Recently, several studies have demonstrated that astro-
cytes generated from hiPSCs mimic normal development
and functions in vivo (Ruiz et al., 2010; Shaltouki et al.,
2013). Exposure to FGF was sufficient to induce a mature
quiescent spinal cord astrocyte phenotype (Roybon et al.,(D and E) Mitochondrial ROS levels were measured by MitoSOX stainin
neurons with the above treatments are shown in (D), and quantificatio
experiments; mean ± SEM, with five cells quantified per experiment).
(F and G) Assessment of intracellular ROS levels measured by EPR sp
quantifications are shown in (G) (n = 3 independent experiments; me
*p < 0.05 versus the vehicle group (C, E, and G). Statistical analysis wa
One-way ANOVA was used for repeated measure analysis, followed b
parisons (A–C, E, and G).
370 Stem Cell Reports j Vol. 10 j 366–374 j February 13, 20182013). CNTF has been shown to direct differentiation of
precursor cells into astrocytes while inhibiting neuronal
differentiation (Bonni et al., 1997). By application of FGF
at the astroglial progenitor stage andCNTF at the late stage,
we directed hiPSCs into mature GFAP-positive astrocytes
9 months after astroglial induction.
In theCNS, astrocytes have beenwidely shown to protect
neurons fromoxidative insults (Shih et al., 2003; Sofroniew
andVinters, 2010). The co-culture systemoffers amodel for
mimicking the in vivo environment for detailed study of
the astrocyte-neuron coordination relationship. In this
study, using transwell inserts plated with mature astro-
cytes, mitochondrial development and differential ability
were restored in DA neurons with mitochondrial respira-
tory inhibitor insult. Similarly, incubation of astrocyte
conditioned medium protects against mitochondrial
toxin-induced defects in mitochondrial function, differen-
tiation, and synaptogenesis in hiPSC line-induced human
DA neurons (Figure S2). These findings indicate that
astrocytes are of key importance in modulating neuronal
mitochondrial dysfunction induced by mitochondrial
insults in vivo.
Mitochondria, highly dynamic organelles and the pri-
mary energy-generating system, contain complex struc-
tures involved in multiple processes, including energy
metabolism, ROS generation, andmitochondrial dynamics
and distribution. Mitochondrial defects occur in a wide
variety of degenerative diseases such as aging, mal-neuro-
development, and neurodegenerative diseases (Mattson
et al., 2008). Excess mitochondrial ROS in NPCs could
lead to mitochondrial dysfunctions, resulting in failure of
DAneurons to differentiate (Fang et al., 2016a). Since astro-
cytes are potent scavengers of ROS, neurons are damaged
by oxidative stress triggered by the impaired redox
scavenging ability of dysfunctional astrocytes (Drukarch
et al., 1998). Indeed, astroglial-neuronal co-culture reduced
intracellular mitochondrial ROS levels and restored
mitochondrial function along with differentiation of DA
neurons insulted by mitochondrial toxin, suggesting the
protective effect of astrocytes on DA neuronal function
and differentiation is, at least in part, via suppressing ROS
to stabilize mitochondrial functions.
Mitochondrial ROS is a strong stimulus, which activates
many signal pathways and transcription factors, includingg. Representative images for MitoSOX staining for hiPSC-derived DA
n of MitoSOX staining intensity is shown in (E) (n = 3 independent
Scale bars, 10 mm in (D).
ectroscopy. Representative images for EPR are shown in (F), and
an ± SEM).
s performed using Statview software (SAS Institute, Version 5.0.1).
y Fisher’s protected least significant difference for post hoc com-
Figure 4. Effect of Astrocyte Co-culture on Mitochondrial Dynamic Parameters in hiPSC-Derived DA Neurons under KCN or Rote-
none Treatment
(A) Cumulative distribution data showed increases in the numbers of long mitochondria in hiPSC-derived DA neurons treated with KCN or
rotenone with or without astrocyte co-culture.
(B andC)Averagemitochondrial travel distance (B) andmitochondrial travel velocity (C)were calculated. Longermitochondrial travel distance
and higher mitochondrial travel velocity were obtained from DA neurons with astrocyte co-culture. **p < 0.01 versus the vehicle group.
(D and E) Higher percentage of movable and lower percentage of stationary (D) and more anterograde and retrograde movable mito-
chondria (E) in DA neurons with astrocyte co-culture. n = 3 independent experiments; mean ± SEM, with 10 mitochondrial movements
quantified per experiment in (B)–(E). **p < 0.01 versus the open and gray bars in the KCN- and rotenone-treated groups without
astrocyte (), respectively. #p < 0.05 and ##p < 0.01 versus the open and gray bars in the KCN-treated groups (), respectively. 6p < 0.05
and 66p < 0.01 versus the open and gray bars in the rotenone-treated groups (), respectively. Statistical analysis was performed using
Statview software (SAS Institute, Version 5.0.1). One-way ANOVA was used for repeated measure analysis, followed by Fisher’s protected
least significant difference for post hoc comparisons (B–E).
(F) Kymographs generated from live-imaging movies represent hiPSC-derived DA neurons cultured with above treatments. In the kymo-
graphs, the x axis is mitochondrial position and the y axis represents the time lapse of 0–120 s. Vertical white lines represent stationary
mitochondria and diagonal lines represent moving mitochondria. Anterograde movements are from left to right and retrograde movements
are from right to left. Scale bar, 10 mm.nuclear factor kB and p38 or ERKmitogen-activated protein
(MAP) kinases. Oxidative stress-mediated activation of p38
MAP kinase contributes to aberrant axonal mitochondrial
transport and aberrant mitochondrial dynamics and func-
tion (Yu et al., 2016, 2017). Disruption of ERK MAP kinasesignaling perturbs the balance of mitochondrial dynamics
via increased mitochondrial fission protein Dlp1 expres-
sion in Alzheimer’s disease trans-mitochondrial ‘‘cybrid’’
(cytoplasmic hybrid) neuronal cells (Gan et al., 2014,
2015). Our most recent study demonstrated the link ofStem Cell Reports j Vol. 10 j 366–374 j February 13, 2018 371
mitochondrial ROS to mitochondrial clearance through
the PINK1-mediated autophagy pathway to maintain
homeostasis of mitochondria (Du et al., 2017). Thus,
mitochondrial ROS-initiated signals may contribute
importantly to the astrocyte-involved DA neuronal matu-
ration and synaptogenesis.
Mitochondria continuously undergo fission and fusion
cycles. During DA neuronal differentiation, mitochondria
favor the fusion process (Fang et al., 2016a). The fission
and fusion balance is maintained via quality control of
mitochondrial proteins, such as Drp1, a key mitochondrial
fission protein found to be indispensable in somatic cell
reprogramming to pluripotency (Vazquez-Martin et al.,
2012), and fusion proteins. Importantly, mitochondrial
trafficking regulator Miro1 (Mitochondrial Rho GTPase
1), a key factor in normal embryonic development, is also
involved in the differentiation of iPSCs (Chen et al.,
2003; Yamaoka et al., 2011).
In addition, multiple trophic factors as bFGF, BDNF,
GDNF, and NGF, derived from astrocytes, have been impli-
cated in regulatingmesencephalicDAneuronal survival, dif-
ferentiation, and synaptic plasticity in vitro and in vivo (Liu
et al., 2015; Yang et al., 2014). These tropic factors are poten-
tially important for the astrocyte-involved mitochondrial
improvement, synaptogenesis, and development of DA.
Endoplasmic reticulum (ER) stress results in accumula-
tion of unfolded or misfolded proteins in the ER lumen.
ER and mitochondria form networks essential to maintain
cellular homeostasis; therefore, ER stress perturbs mito-
chondrial function (Malhotra and Kaufman, 2011). Under
chronic KCN and rotenone treatments, the protein disul-
fide isomerase, a stress protein abundant in ER, and the
ER chaperone glucose-regulated protein 78 were elevated
in the DA neurons (Figure S3). Notably, co-culture with
astrocytes almost abolished KCN- or rotenone-mediated
upregulation of these ER stress markers. These results sug-
gest a possible link of mitochondrial dysfunction to ER
stress via astrocytes, contributing to the normal differenti-
ation and synaptogenesis in DA neurons.
Mitochondrial dysfunction and oxidative stress play a
major role in the pathogenesis of PD. Deficiency of mito-
chondrial complex I of the respiratory chain has long
been implicated in the cause of the degeneration of
PD-affected neurons (Mizuno et al., 1998). In addition,
combined decreased complex I and IV activity was seen
in the platelet mitochondria of PD (Benecke et al.,
1993) and 1-methyl-4-phenyl 1,2,3,6-tetrahydropyridine
(MPTP)- or 6-hydroxydopamine-induced animal models
of PD (Desai et al., 1996; Glinka and Youdim, 1995).
Here, we induced DA neuron differentiation by co-culture
with mature astrocytes to mimic the in vivo neuronal-
astroglial interaction environment. Therefore, evaluation
of the consequences of mitochondrial toxin-mediated372 Stem Cell Reports j Vol. 10 j 366–374 j February 13, 2018inhibition of mitochondrial respiratory function via
complex I or IV on dopamine neurons holds a potential
significance for the pathogenesis of DA degeneration rele-
vant to the PD pathology.
In summary, we have clearly demonstrated the direct role
of mitochondria in DA neuron maturation and an active
astrocyte-neuron coordination relationship. The present
model provides an approach for the study of abnormal
mitochondrial structure, function, and dynamics in the
pathogenesis of neurodegenerative diseases and, impor-
tantly, an approach for therapeutic discovery in neurode-
generative diseases such as PD.EXPERIMENTAL PROCEDURES
hiPSC Culture
Bone marrow 2-3 (BM2-3) from hiPSCs passaged 16–20 times were
obtained from Dr. Sunita L. D’Souza. This BM2-3 iPSC line was
derived from the bone marrow of a clinically normal human sub-
ject and verified by fluorescence in situ hybridization test showing
46,XX. Cytogenetic analysis of culturedhuman stem cells revealed
a normal female karyotype. This analysis did not show any
evidence of a clinically significant numerical or structural chromo-
somal abnormality (Fang et al., 2016a). Cells were maintained un-
der feeder-free conditions using Matrigel (BD Biosciences)-coated
six-well tissue culture plates in Essential 8 Medium (Life Technolo-
gies), supplemented with 10 mM ROCK inhibitor Y27632 (Life
Technologies). Cells were routinely passaged as small clumps using
a previously described EDTA method (Fang et al., 2016a).
Neuron and Astrocyte Co-culture System
For co-culture experiments, 2.53 104 astrocytes per well were first
seeded on the 12-well transwell cell culture insert system (pore size
0.4 mm; Falcon, USA) and allowed to grow for 5 days. On day 6,
astroglial medium was changed to DA neuronal differentiation
medium. After 2 days, the transwell inserts were placed into wells
of NPCs during induction, and future experiments were conducted
2 days after the insertion of the astroglial transwells (Figure 1A).
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